Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial

Shuhong Gao1, Zhengzheng Shi2, Xin Li3

  • 1Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China.

Oncology Reports
|February 14, 2018
PubMed

Insights

Fatostatin effectively inhibits endometrial carcinoma (EC) cell growth and spread by blocking sterol regulatory element-binding protein (SREBP) pathways. This compound induces apoptosis and may offer a new therapeutic strategy for EC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Fatostatin is a sterol regulatory element-binding protein (SREBP) pathway inhibitor with known antitumor activity.
  • Endometrial carcinoma (EC) is a significant gynecological malignancy requiring novel therapeutic approaches.

Purpose of the Study:

  • To investigate the antitumor effects and underlying mechanisms of fatostatin in endometrial carcinoma (EC) cells.
  • To determine if fatostatin can inhibit EC cell proliferation, invasion, and migration.
  • To elucidate the impact of fatostatin on SREBP pathway activity and apoptosis in EC.

Main Methods:

  • Cell viability and colony formation assays were performed to assess proliferation.
  • Invasion and migration assays were used to evaluate cellular motility.
  • Western blotting was employed to measure protein expression levels of SREBPs, downstream targets, and apoptosis markers (caspase-9, caspase-3, PARP).
  • Quantitative assays measured free fatty acid and total cholesterol levels.

Main Results:

  • Fatostatin significantly inhibited EC cell viability, colony formation, invasion, and migration.
  • Fatostatin induced cell cycle arrest at the G2/M phase and promoted caspase-mediated apoptosis.
  • Protein and mRNA levels of nuclear SREBPs and their downstream genes were downregulated.
  • Levels of free fatty acids and total cholesterol were decreased in EC cells treated with fatostatin.

Conclusions:

  • Fatostatin demonstrates potent antitumor effects in endometrial carcinoma by inhibiting SREBP-regulated metabolic pathways.
  • The mechanism involves downregulation of SREBP activity, induction of apoptosis, and reduction of key metabolites.
  • Fatostatin represents a promising therapeutic candidate for endometrial carcinoma treatment.

Related Concept Videos

Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.7K
What is Metabolism?00:52

What is Metabolism?

Overview
132.7K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.4K